δ-Opioid Receptor Antagonists as a New Concept for Central Acting Antitussive Drugs

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.15, Iss.3, 2002-06, pp. : 235-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-peptidic δ opioid receptor agonists and antagonists (2000 – 2012)

By Fujii Hideaki Takahashi Toshihiro Nagase Hiroshi

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1181-1208

Informa Healthcare

Access to resources Recommend Favorite

Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs

By Norman Peter

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 55-66

Informa Healthcare

Access to resources Recommend Favorite

Novel pharmacological targets and progression of new antitussive drugs

By McLeod Robbie L Tulshian Deen B Hey John A

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. : 1501-1512

Informa Healthcare

Access to resources Recommend Favorite

Ultraselective antagonists of the d-opioid receptor

By Lazarus L.H. Salvadori S. Temussi P.A. Balboni G. Guerrini R. Bryant S.D. Cooper P.S.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite

AMPA Receptor Antagonists with Additional Mechanisms of Action: New Opportunities for Neuroprotective Drugs?

Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. : 941-951

Bentham Science Publishers

Access to resources Recommend Favorite